CAL 27 is an oral adenosquamous carcinoma cell line

Oral Oncology

Volumn 45, Issue 11, 2009, Pages

  Jiang, Lu ^a   Ji, Ning ^a,b   Zhou, Yu ^a   Li, Jing ^a,b   Liu, Xianting ^a,b   Wang, Zhi ^a   Chen, Qianming ^a   Zeng, Xin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Adenosquamous carcinoma; CAL 27; Cell line

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAL 27 CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; DNA FINGERPRINTING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SHORT TANDEM REPEAT; TONGUE CARCINOMA; XENOGRAFT;

CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; TRANSPLANTATION, HETEROLOGOUS;

EID: 70349976986     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.06.001     Document Type: Article

References (18)

1. Gioanni J., Fischel J.L., Lambert J.C., Demard F., Mazeau C., Zanghellini E., et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24 9 (1988) 1445-1455
2. Jiang L., Zeng X., Yang H., Wang Z., Shen J., Bai J., et al. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer 123 8 (2008) 1779-1786
3. Aznavoorian S., Moore B.A., Alexander-Lister L.D., Hallit S.L., Windsor L.J., and Engler J.A. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 61 16 (2001) 6264-6275
4. Simoens C., Korst A.E., De Pooter C.M., Lambrechts H.A., Pattyn G.G., Faircloth G.T., et al. In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects. Brit J Cancer 89 12 (2003) 2305-2311
5. Herak Bosnar M., Bago R., Konjevoda P., and Pavelić J. Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray. Neoplasma 55 5 (2008) 447-454
6. Tseng M.Y., Liu S.Y., Chen H.R., Wu Y.J., Chiu C.C., Chan P.T., et al. Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. Oral Oncol 45 9 (2009) 771-776
7. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Serpico R., Fanali S., et al. P120(cat) delocalization in cell lines of oral cancer. Oral Oncol 38 1 (2002) 64-72
8. Simons A.L., Fath M.A., Mattson D.M., Smith B.J., Walsh S.A., Graham M.M., et al. Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-d-glucose correlates with increased 18F-FDG uptake as determined by PET imaging. Int J Radiat Oncol Biol Phys 69 4 (2007) 1222-1230
9. Rosenthal E.L., Vidrine D.M., and Zhang W. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo. Laryngoscope 116 7 (2006) 1086-1092
10. Lee T.K., Poon R.T., Wo J.Y., Ma S., Guan X.Y., Myers J.N., et al. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res 67 18 (2007) 8800-8809
11. LoTempio M.M., Veena M.S., Steele H.L., Ramamurthy B., Ramalingam T.S., Cohen A.N., et al. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11 19 Pt 1 (2005) 6994-7002
12. Alderson R., Gohari-Fritsch S., Olsen H., Roschke V., Vance C., and Connolly K. In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells. Cancer Chemother Pharmacol 50 3 (2002) 202-212
13. Azemar M., Schmidt M., Arlt F., Kennel P., Brandt B., Papadimitriou A., et al. Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo. Int J Cancer 86 2 (2000) 269-275
14. McLaughlin P.J., Levin R.J., and Zagon I.S. The opioid growth factor receptor in human head and neck squamous cell carcinoma. Int J Mol Med 5 2 (2000) 191-196
15. Masters J. False cell lines. Carcinogenesis 23 2 (2002) 371
16. Nardone R.M. Eradication of cross-contaminated cell lines: a call for action. Cell Biol Toxicol 23 6 (2007) 367-372
17. MacLeod R.A., Dirks W.G., Matsuo Y., Kaufmann M., Milch H., and Drexler H.G. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83 4 (1999) 555-563
18. Azari S., Ahmadi N., Tehrani M.J., and Shokri F. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran. Biologicals 35 3 (2007) 195-202